BIOPONTIS ALLIANCE RARE DISEASE FOUNDATION INC (EIN 464764835) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

ERIK TAMBUYZER PHD

Phone

9196240841

Tax Period

2019-01-01 to 2019-12-31

BIOPONTIS ALLIANCE RARE DISEASE FOUNDATION INC, founded in 2014, is a micro nonprofit that reported $95K in total revenue in fiscal year 2019. Revenue fell 55% from the prior year — a significant decline worth monitoring.

Mission

THE BIOPONTIS ALLIANCE RARE DISEASE FOUNDATION IS A NONPROFIT CORPORATION THAT BRINGS TOGETHER RARE DISEASE PATIENT ADVOCACY ORGANIZATIONS, ACADEMIC RESEARCH CENTERS, CONTRACT RESEARCH COMPANIES, AND THE BIOMEDICAL INDUSTRY TO TRANSLATE RESEARCH INTO POTENTIAL TREATMENTS BY FOCUSING ON THE EARLIEST STAGES OF PRODUCT DEVELOPMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2019)

Revenue Breakdown

Contributions & Grants $91,725

Program Service Revenue $0

Investment Income $0

Other Revenue $3,000

TOTAL REVENUE $94,725

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $876

Program Expenses $36,517

Other Expenses $96,516

TOTAL EXPENSES $96,516

Year-over-Year Comparison

	2019	2018	Change
Revenue	$94,725	$211,351	-0.6%
Expenses	$96,516	$225,430	-0.6%
Net Income	$-1,791	$-14,079	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$36,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GILBERT CHIP CARNATHAN PHD	CHIEF SCIENT	10.00	Officer	$36,000	$0	$36,000
SUSAN R KAHN	DIRECTOR & T	3.00	Officer Director	$0	$0	$0
HOWARD LIEBMAN	DIRECTOR	3.00	Director	$0	$0	$0
JEAN-JACQUES CASSIMAN MD	DIRECTOR	3.00	Director	$0	$0	$0
WARREN STRITTMATTER MD	DIRECTOR	3.00	Director	$0	$0	$0
CHRISTIAN POLICARD PHD	DIRECTOR	3.00	Director	$0	$0	$0
DAVID SPENCER PHD	VICE-CHAIRPE	5.00	Officer Director	$0	$0	$0
ERIK TAMBUYZER PHD	CHAIRPERSON	15.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$94,725	$96,516	$19,562	$-1,791
2018	$211,351	$225,430	$3,273	$-14,079

BIOPONTIS ALLIANCE RARE DISEASE FOUNDATION INC